The U.S. diabetes monitoring, treatment, and drug delivery market was valued at $48 billion in 2024 and is projected to grow at a CAGR of 7.3%, reaching $79 billion by 2031.
This report covers key market segments, including:
Blood Glucose Meters, Blood Glucose Test Strips, Lancets
Continuous Glucose Monitoring (CGM) & Flash Glucose Monitoring (FGM)
Insulin & GLP-1 Receptor Agonists (e.g., Ozempic®)
Insulin Pens, Insulin Syringes, and Insulin Pumps
Key Market Segment Insights
The largest and fastest-growing segment in 2024 was the insulin and GLP-1 receptor agonist market, which accounted for the majority of total market value. The growth of GLP-1 therapies is driven by:
Rising prevalence of type 2 diabetes and obesity
Increased demand for innovative treatment solutions
Advancements in therapies that address both diabetes and obesity
Market Data Highlights
The report includes:
Unit Sales, Average Selling Prices, Market Size & Growth Trends
Market Drivers & Limiters
Market Forecasts Until 2031 and Historical Data from 2021
Competitive Analysis & Market Shares
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
U.S. Diabetes Market Trends
Smart Reusable Insulin Pens: The demand for smart insulin pens is increasing due to their ability to track doses, calculate insulin requirements, and provide reminders. These devices enhance diabetes management and offer greater convenience despite higher pricing.
Technological Advancements: Continuous improvements in CGM, insulin delivery systems, and digital health solutions are expected to drive the market forward.
Market Share Insights
Top Competitors in the U.S. Diabetes Market (2024):
1 Novo Nordisk
Market leader in insulin and second in insulin pens.
Top position in ultra-long-acting & ultra-rapid-acting insulin.
Only competitor in the rapid-acting insulin market.
GLP-1 portfolio includes Ozempic®, Rybelsus®, and Xultophy®.
2 Eli Lilly
Second-largest competitor in the insulin market.
Leader in premixed insulin, ultra-rapid-acting insulin, and human insulin.
GLP-1 portfolio includes Trulicity®, Mounjaro®, and Zepbound®.
3 Dexcom
Dominates the continuous glucose monitoring (CGM) market.
Strong sales from G6® (FDA approval in 2018) and G7 (FDA approval in 2023).
Market Segmentation Summary
This report suite includes all relevant market data, but individual MedCore reports are available for specific segments.
Blood Glucose Meter Market
Segmented Into: Personal & Professional
Blood Glucose Test Strip Market
Segmented Into: Personal & Professional
Lancet Market
Segmented Into: Personal & Professional
Continuous Glucose Monitoring (CGM) Market
Segmented Into: Personal & Professional
Flash Glucose Monitoring (FGM) Market
Segmented Into: Readers & Sensors
Insulin and GLP-1 Market
Insulin Types: Long-Acting, Ultra-Long-Acting, Rapid-Acting, Ultra-Rapid-Acting, Premixed, Human
GLP-1 Segments:
Diabetes Care: GLP-1 Injection, GLP-1 Oral
Obesity Care: GLP-1 Injection
Insulin Pen Market
Segmented Into: Reusable Pens & Pen Needles
Insulin Syringe Market
Segmented Into: Conventional & Safety Syringes
Insulin Pump Market
Segmented Into: Durable, Patch, and Simple Pumps
Global Research Scope
Report Attributes and Details:
Region: United States
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023
Quantitative Coverage:
Market Size, Market Shares, Market Forecasts, Growth Rates
Units Sold, Average Selling Prices
Qualitative Coverage:
COVID-19 Impact
Market Trends & Limiters
Competitive Analysis & SWOT for Leading Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls & Disruptive Technologies
Disease Overviews
Data Sources:
Industry Leader Interviews
Government & Regulatory Data
Hospital & Private Sector Data
Import & Export Records
iData Research Internal Database
- Executive Summary
- U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview
- Competitive Analysis
- Emerging Markets and Technologies
- Market Developments
- Market Trends
- Market Segmentation
- Key Report Updates
- Version History
- research methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
- Disease Overview
- 2.1 Introduction
- 2.1.1 Types of Diabetes
- 2.1.2 Diabetes Complications
- 2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
- 2.1.4 Signs and Symptoms
- 2.1.5 Diabetes Monitoring
- 2.1.6 Treatment
- 2.1.7 Drug Delivery Systems
- U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview
- 3.1 Introduction
- 3.2 Market Overview & Trend Analysis
- 3.3 Drivers and Limiters
- 3.3.1 Market Drivers
- 3.3.2 Market Limiters
- 3.4 Competitive Market Share Analysis
- 3.5 Mergers and Acquisitions
- patient demographics AND INSTALLED BASE
- 4.1 Patient Demographics
- 4.1.1 Diagnosed Diabetes Patient Population by Type
- 4.1.2 Diagnosed Type 2 Diabetes Patient Population by Type
- 4.1.3 Diagnosed Insulin-Dependent Diabetes Patient Population by Type
- 4.2 Installed Base Analysis and Forecast
- 4.2.1 Personal Glucose Monitoring Installed Base by Segment
- 4.2.2 Personal CGM Installed Base by Patient Type
- 4.2.3 Insulin User Installed Base by Segment
- 4.2.4 Durable Pump Installed Base by Diabetes Type
- 4.2.5 Patch Pump Installed Base by Diabetes Type
- 4.2.6 MDI Installed Base by Segment
- 4.2.7 MDI Installed Base by Diabetes Type
- Blood glucose meter Market
- 5.1 Introduction
- 5.2 Market Overview
- 5.3 Market Analysis and Forecast
- 5.3.1 Personal Blood Glucose Meter Market
- 5.3.2 Professional Blood Glucose Meter Market
- 5.4 Drivers and Limiters
- 5.4.1 Market Drivers
- 5.4.2 Market Limiters
- 5.5 Competitive Market Share Analysis
- Blood Glucose test strip Market
- 6.1 Introduction
- 6.2 Market Overview
- 6.3 Market Analysis and Forecast
- 6.3.1 Total Blood Glucose Test Strip Market
- 6.3.2 Personal Blood Glucose Test Strip Market
- 6.3.2.1 Medicare/Medicaid Personal Blood Glucose Test Strip Market
- 6.3.2.2 Managed Care Personal Blood Glucose Test Strip Market
- 6.3.2.3 Personal Cash Blood Glucose Test Strip Market
- 6.3.3 Professional Blood Glucose Test Strip Market
- 6.4 Drivers and Limiters
- 6.4.1 Market Drivers
- 6.4.2 Market Limiters
- 6.5 Competitive Market Share Analysis
- Lancet Market
- 7.1 Introduction
- 7.2 Market Overview
- 7.3 Market Analysis and Forecast
- 7.3.1 Total Lancet Market
- 7.3.2 Personal Lancet Market
- 7.3.3 Professional Lancet Market
- 7.4 Drivers and Limiters
- 7.4.1 Market Drivers
- 7.4.2 Market Limiters
- 7.5 Competitive Market Share Analysis
- Continuous Glucose MonitorinG Market
- 8.1 Introduction
- 8.2 Market Overview
- 8.3 Market Analysis and Forecast
- 8.3.1 Personal Continuous Glucose Monitoring Market
- 8.3.1.1 Personal Continuous Glucose Monitoring Receiver Market
- 8.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market
- 8.3.1.3 Personal Continuous Glucose Monitoring Sensor Market
- 8.3.2 Professional Continuous Glucose Monitoring Market
- 8.3.2.1 Professional Continuous Glucose Monitoring System Market
- 8.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market
- 8.3.2.3 Professional Continuous Glucose Monitoring Sensor Market
- 8.4 Drivers and Limiters
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
- 8.5 Competitive Market Share Analysis
- 8.5.1 Continuous Glucose Monitoring Market Installed Base Share
- Flash Glucose monitoring Market
- 9.1 Introduction
- 9.2 Market Overview
- 9.3 Market Analysis and Forecast
- 9.3.1 Flash Glucose Monitoring Reader Market
- 9.3.2 Flash Glucose Monitoring Sensor Market
- 9.4 Drivers and Limiters
- 9.4.1 Market Drivers
- 9.4.2 Market Limiters
- 9.5 Competitive Market Share Analysis
- Insulin and GLP-1 Market
- 10.1 Introduction
- 10.1.1 Insulin Types
- 10.1.1.1 Rapid-Acting Insulin Analog
- 10.1.1.2 Ultra-Rapid-Acting Insulin Analog
- 10.1.1.3 Regular Human Insulin
- 10.1.1.4 Intermediate-Acting Human Insulin
- 10.1.1.5 Long-Acting Insulin Analog
- 10.1.1.6 Ultra-Long-Acting Insulin Analog
- 10.1.1.7 Premixed Insulin
- 10.2 Market Overview
- 10.3 Market Analysis and Forecast
- 10.3.1 Insulin Market
- 10.3.1.1 Long-Acting Insulin Market
- 10.3.1.2 Ultra-Long-Acting Insulin Market
- 10.3.1.3 Rapid-Acting Insulin Market
- 10.3.1.4 Ultra-Rapid-Acting Insulin Market
- 10.3.1.5 Premixed Insulin Market
- 10.3.1.6 Human Insulin Market
- 10.3.2 GLP-1 Market
- 10.3.2.1 GLP-1 Diabetes Care Injection Market
- 10.3.2.2 GLP-1 Diabetes Care Oral Market
- 10.3.2.3 GLP-1 Obesity Care Injection Market
- 10.4 Drivers and Limiters
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
- 10.5 Competitive Market Share Analysis
- Insulin pen Market
- 11.1 Introduction
- 11.2 Market Overview
- 11.3 Market Analysis and Forecast
- 11.3.1 Reusable Pen Market
- 11.3.1.1 Standard Reusable Pen Market
- 11.3.1.2 Smart Reusable Pen Market
- 11.3.2 Pen Needle Market
- 11.3.2.1 Conventional Pen Needle Market
- 11.3.2.2 Safety Pen Needle Market
- 11.4 Drivers and Limiters
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
- 11.5 Competitive Market Share Analysis
- Insulin Syringe Market
- 12.1 Introduction
- 12.2 Market Overview
- 12.3 Market Analysis and Forecast
- 12.3.1 Total Insulin Syringe Market
- 12.3.2 Conventional Insulin Syringe Market
- 12.3.3 Safety Insulin Syringe Market
- 12.4 Drivers and Limiters
- 12.4.1 Market Drivers
- 12.4.2 Market Limiters
- 12.5 Competitive Market Share Analysis
- Insulin pump Market
- 13.1 Introduction
- 13.1.1 Durable Insulin Pumps
- 13.1.2 Patch Insulin Pumps
- 13.1.3 Simple Insulin Pumps
- 13.2 Market Overview
- 13.3 Market Analysis and Forecast
- 13.3.1 Durable Insulin Pump Market
- 13.3.1.1 Durable Pump Market
- 13.3.1.2 Infusion Set Market
- 13.3.1.3 Pump Reservoir Market
- 13.3.2 Patch Insulin Pump Market
- 13.3.2.1 Patch Pump System Market
- 13.3.2.2 Insulin Pod Market
- 13.3.3 Simple Insulin Pump Market
- 13.4 Drivers and Limiters
- 13.4.1 Market Drivers
- 13.4.2 Market Limiters
- 13.5 Competitive Market Share Analysis
- 13.5.1 Durable Insulin Pump Market
- 13.5.2 Insulin Pump Market Installed Base Share
- Abbreviations
- List of Charts
- Chart 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2024 – 2031
- Chart 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2024 & 2031
- Chart 3-1: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 – 2031
- Chart 3-2: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2024
- Chart 4-1: Diagnosed Diabetes Patient Population by Type, U.S., 2021 – 2031
- Chart 5-1: Blood Glucose Meter Market by Segment, U.S., 2021 – 2031
- Chart 5-2: Leading Competitors, Blood Glucose Meter Market, U.S., 2024
- Chart 6-1: Blood Glucose Test Strip Market by Segment, U.S., 2021 – 2031
- Chart 6-2: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2024
- Chart 7-1: Lancet Market by Segment, U.S., 2021 – 2031
- Chart 7-2: Leading Competitors, Lancet Market, U.S., 2024
- Chart 8-1: Continuous Glucose Monitoring Market by Segment, U.S., 2021 – 2031
- Chart 8-2: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2024
- Chart 9-1: Flash Glucose Monitoring Market by Segment, U.S., 2021 – 2031
- Chart 10-1: Insulin and GLP-1 Market by Segment, U.S., 2021 – 2031
- Chart 10-2: Leading Competitors, Insulin and GLP-1 Market, U.S., 2024
- Chart 11-1: Insulin Pen Market by Segment, U.S., 2021 – 2031
- Chart 11-2: Leading Competitors, Insulin Pen Market, U.S., 2024
- Chart 12-1: Insulin Syringe Market by Segment, U.S., 2021 – 2031
- Chart 12-2: Leading Competitors, Insulin Syringe Market, U.S., 2024
- Chart 13-1: Insulin Pump Market by Segment, U.S., 2021 – 2031
- Chart 13-2: Leading Competitors, Insulin Pump Market, U.S., 2024
- List of Figures
- Figure 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2024 (1 of 2)
- Figure 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2024 (2 of 2)
- Figure 1-3: Companies Researched in this Report, U.S., 2024 (1 of 2)
- Figure 1-4: Companies Researched in this Report, U.S., 2024 (2 of 2)
- Figure 1-5: Recent Events in the Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2019 – 2024 (1 of 2)
- Figure 1-6: Recent Events in the Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2019 – 2024 (2 of 2)
- Figure 1-7: Factors Impacting the Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S. (1 of 2)
- Figure 1-8: Factors Impacting the Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S. (2 of 2)
- Figure 1-9: Diabetes Monitoring, Treatment, and Drug Delivery Market Segmentation (1 of 2)
- Figure 1-10: Diabetes Monitoring, Treatment, and Drug Delivery Market Segmentation (2 of 2)
- Figure 1-11: Patient Demographics and Installed Base Segmentation
- Figure 1-12: Key Report Updates
- Figure 1-13: Version History
- Figure 3-1: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 – 2031 (US$M) (1 of 2)
- Figure 3-2: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 – 2031 (US$M) (2 of 2)
- Figure 3-3: Leading Competitors, Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2024 (1 of 2)
- Figure 3-4: Leading Competitors, Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2024 (2 of 2)
- Figure 4-1: Diagnosed Diabetes Patient Population by Type, U.S., 2021 – 2031
- Figure 4-2: Diagnosed Type 2 Diabetes Patient Population by Type, U.S., 2021 – 2031
- Figure 4-3: Diagnosed Insulin-Dependent Diabetes Patient Population by Type, U.S., 2021 – 2031
- Figure 4-4: Glucose Monitoring Installed Base by Segment, U.S., 2021 – 2031
- Figure 4-5: Personal CGM Installed Base by Patient Type, U.S., 2021 – 2031
- Figure 4-6: Insulin User Installed Base by Segment, U.S., 2021 – 2031
- Figure 4-7: Durable Pump Installed Base by Diabetes Type, U.S., 2021 – 2031
- Figure 4-8: Patch Pump Installed Base by Diabetes Type, U.S., 2021 – 2031
- Figure 4-9: MDI Installed Base by Segment, U.S., 2021 – 2031
- Figure 4-10: MDI Installed Base by Diabetes Type, U.S., 2021 – 2031
- Figure 5-1: Blood Glucose Meter Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 5-2: Personal Blood Glucose Meter Market, U.S., 2021 – 2031
- Figure 5-3: Professional Blood Glucose Meter Market, U.S., 2021 – 2031
- Figure 5-4: Leading Competitors, Blood Glucose Meter Market, U.S., 2024
- Figure 6-1: Blood Glucose Test Strip Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 6-2: Total Blood Glucose Test Strip Market, U.S., 2021 – 2031
- Figure 6-3: Personal Blood Glucose Test Strip Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 6-4: Total Personal Blood Glucose Test Strip Market, U.S., 2021 – 2031
- Figure 6-5: Medicare/Medicaid Personal Blood Glucose Test Strip Market, U.S., 2021 – 2031
- Figure 6-6: Managed Care Personal Blood Glucose Test Strip Market, U.S., 2021 – 2031
- Figure 6-7: Personal Cash Blood Glucose Test Strip Market, U.S., 2021 – 2031
- Figure 6-8: Professional Blood Glucose Test Strip Market, U.S., 2021 – 2031
- Figure 6-9: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2024
- Figure 7-1: Lancet Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 7-2: Total Lancet Market, U.S., 2021 – 2031
- Figure 7-3: Personal Lancet Market, U.S., 2021 – 2031
- Figure 7-4: Professional Lancet Market, U.S., 2021 – 2031
- Figure 7-5: Leading Competitors, Lancet Market, U.S., 2024
- Figure 8-1: Continuous Glucose Monitoring Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 8-2: Personal Continuous Glucose Monitoring Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 8-3: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2021 – 2031
- Figure 8-4: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2021 – 2031
- Figure 8-5: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2021 – 2031
- Figure 8-6: Professional Continuous Glucose Monitoring Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 8-7: Professional Continuous Glucose Monitoring System Market, U.S., 2021 – 2031
- Figure 8-8: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2021 – 2031
- Figure 8-9: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2021 – 2031
- Figure 8-10: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2024
- Figure 8-11: Leading Competitors, Continuous Glucose Monitoring Market Installed Base Share, U.S., 2024
- Figure 9-1: Flash Glucose Monitoring Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 9-2: Flash Glucose Monitoring Reader Market, U.S., 2021 – 2031
- Figure 9-3: Flash Glucose Monitoring Sensor Market, U.S., 2021 – 2031
- Figure 9-4: Leading Competitors, Flash Glucose Monitoring Market, U.S., 2024
- Figure 10-1: Insulin and GLP-1 Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 10-2: Insulin Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 10-3: Total Insulin Market, U.S., 2021 – 2031
- Figure 10-4: Long-Acting Insulin Market, U.S., 2021 – 2031
- Figure 10-5: Ultra-Long-Acting Insulin Market, U.S., 2021 – 2031
- Figure 10-6: Rapid-Acting Insulin Market, U.S., 2021 – 2031
- Figure 10-7: Ultra-Rapid-Acting Insulin Market, U.S., 2021 – 2031
- Figure 10-8: Premixed Insulin Market, U.S., 2021 – 2031
- Figure 10-9: Human Insulin Market, U.S., 2021 – 2031
- Figure 10-10: GLP-1 Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 10-11: Total GLP-1 Market, U.S., 2021 – 2031
- Figure 10-12: GLP-1 Diabetes Care Injection Market, U.S., 2021 – 2031
- Figure 10-13: GLP-1 Diabetes Care Oral Market, U.S., 2021 – 2031
- Figure 10-14: GLP-1 Obesity Care Injection Market, U.S., 2021 – 2031
- Figure 10-15: Leading Competitors, Insulin and GLP-1 Market, U.S., 2024
- Figure 10-16: Leading Competitors, Insulin Market, U.S., 2024
- Figure 10-17: Leading Competitors, GLP-1 Market, U.S., 2024
- Figure 11-1: Insulin Pen Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 11-2: Reusable Pen Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 11-3: Total Reusable Pen Market, U.S., 2021 – 2031
- Figure 11-4: Standard Reusable Pen Market, U.S., 2021 – 2031
- Figure 11-5: Smart Reusable Pen Market, U.S., 2021 – 2031
- Figure 11-6: Pen Needle Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 11-7: Total Pen Needle Market, U.S., 2021 – 2031
- Figure 11-8: Conventional Pen Needle Market, U.S., 2021 – 2031
- Figure 11-9: Safety Pen Needle Market, U.S., 2021 – 2031
- Figure 11-10: Leading Competitors, Insulin Pen Market, U.S., 2024
- Figure 12-1: Insulin Syringe Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 12-2: Total Insulin Syringe Market, U.S., 2021 – 2031
- Figure 12-3: Total Conventional Insulin Syringe Market, U.S., 2021 – 2031
- Figure 12-4: Safety Insulin Syringe Market, U.S., 2021 – 2031
- Figure 12-5: Leading Competitors, Insulin Syringe Market, U.S., 2024
- Figure 13-1: Insulin Pump Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 13-2: Durable Insulin Pump Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 13-3: Durable Pump Market, U.S., 2021 – 2031
- Figure 13-4: Infusion Set Market, U.S., 2021 – 2031
- Figure 13-5: Pump Reservoir Market, U.S., 2021 – 2031
- Figure 13-6: Patch Insulin Pump Market by Segment, U.S., 2021 – 2031 (US$M)
- Figure 13-7: Patch Pump System Market, U.S., 2021 – 2031
- Figure 13-8: Insulin Pod Market, U.S., 2021 – 2031
- Figure 13-9: Simple Insulin Pump Market, U.S., 2021 – 2031
- Figure 13-10: Leading Competitors, Insulin Pump Market, U.S., 2024
- Figure 13-11: Leading Competitors, Durable Insulin Pump Market, U.S., 2024
- Figure 13-12: Leading Competitors, Insulin Pump Market Installed Base Share, U.S., 2024
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook